Colombia In-Vitro Diagnostics Market is predicted to reach USD 413.6 Million by 2030

According to the study by Next Move Strategy Consulting, the Colombia In-Vitro Diagnostics Market size is predicted to reach USD 413.6 million, at a CAGR of 4.3% by 2030.

Request a FREE Sample: https://www.nextmsc.com/colombia-in-vitro-diagnostics-market/request-sample

The presence of one of the largest and most developed healthcare system of Colombia serves as a significant growth driver for the in vitro diagnostics (IVD) market.

The expansion of medical devices is further driving Colombia in-vitro diagnostics market growth.

The promising players operating in the Colombia in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.